Omnicell EPS - Earnings per Share 2010-2025 | OMCL
Omnicell eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Omnicell Annual EPS | |
|---|---|
| 2024 | $0.27 |
| 2023 | $-0.45 |
| 2022 | $0.12 |
| 2021 | $1.62 |
| 2020 | $0.74 |
| 2019 | $1.43 |
| 2018 | $0.93 |
| 2017 | $0.79 |
| 2016 | $0.26 |
| 2015 | $0.84 |
| 2014 | $0.83 |
| 2013 | $0.67 |
| 2012 | $0.47 |
| 2011 | $0.30 |
| 2010 | $0.15 |
| 2009 | $0.01 |
| Omnicell Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.15 |
| 2024-12-31 | $0.34 |
| 2024-09-30 | $0.19 |
| 2024-06-30 | $0.08 |
| 2024-03-31 | $-0.34 |
| 2023-12-31 | $-0.32 |
| 2023-09-30 | $0.12 |
| 2023-06-30 | $0.08 |
| 2023-03-31 | $-0.33 |
| 2022-12-31 | $-0.62 |
| 2022-09-30 | $0.37 |
| 2022-06-30 | $0.20 |
| 2022-03-31 | $0.17 |
| 2021-12-31 | $0.28 |
| 2021-09-30 | $0.61 |
| 2021-06-30 | $0.43 |
| 2021-03-31 | $0.30 |
| 2020-12-31 | $0.38 |
| 2020-09-30 | $0.20 |
| 2020-06-30 | $-0.10 |
| 2020-03-31 | $0.26 |
| 2019-12-31 | $0.52 |
| 2019-09-30 | $0.46 |
| 2019-06-30 | $0.37 |
| 2019-03-31 | $0.08 |
| 2018-12-31 | $0.37 |
| 2018-09-30 | $0.33 |
| 2018-06-30 | $0.16 |
| 2018-03-31 | $0.07 |
| 2017-12-31 | $0.82 |
| 2017-09-30 | $0.20 |
| 2017-06-30 | $0.05 |
| 2017-03-31 | $-0.28 |
| 2016-12-31 | $0.25 |
| 2016-09-30 | $0.05 |
| 2016-06-30 | $-0.03 |
| 2016-03-31 | $-0.01 |
| 2015-12-31 | $0.21 |
| 2015-09-30 | $0.22 |
| 2015-06-30 | $0.24 |
| 2015-03-31 | $0.17 |
| 2014-12-31 | $0.25 |
| 2014-09-30 | $0.20 |
| 2014-06-30 | $0.21 |
| 2014-03-31 | $0.17 |
| 2013-12-31 | $0.19 |
| 2013-09-30 | $0.21 |
| 2013-06-30 | $0.17 |
| 2013-03-31 | $0.10 |
| 2012-12-31 | $0.16 |
| 2012-09-30 | $0.20 |
| 2012-06-30 | $0.04 |
| 2012-03-31 | $0.07 |
| 2011-12-31 | $0.11 |
| 2011-09-30 | $0.09 |
| 2011-06-30 | $0.08 |
| 2011-03-31 | $0.02 |
| 2010-12-31 | $0.02 |
| 2010-09-30 | $0.04 |
| 2010-06-30 | $0.06 |
| 2010-03-31 | $0.03 |
| 2009-12-31 | $0.01 |
| 2009-09-30 | $0.03 |
| 2009-06-30 | $0.03 |
| 2009-03-31 | $-0.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.259B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Doximity (DOCS) | United States | $11.290B | 52.27 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.350B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.741B | 58.45 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.541B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.155B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |